U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C10H14N2O4
Molecular Weight 226.2292
Optical Activity ( + )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROXIBARBAL, (+)-

SMILES

CC(O)CC1(CC=C)C(=O)NC(=O)NC1=O

InChI

InChIKey=VNLMRPAWAMPLNZ-UHFFFAOYSA-N
InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16)

HIDE SMILES / InChI

Molecular Formula C10H14N2O4
Molecular Weight 226.2292
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Proxibarbal is a non-sedative barbiturate with a specific anti-serotonin and anti-histamine effect, due to enzyme induction of serotoninase and histaminase. Its lack of unpleasant side-effects. Proxibarbal exists in ring-chain tautomeric equilibrium with the two diastereomers of valofan. Proxibarbal is metabolized to a five-membered lactone. Its only barbituric property is its ability to induce enzymes that destroy a surplus of neurohormones and rid people of their neurovegetative sufferings, including migraine and other types of vascular headache. Side effects are: dizziness, drowsiness, dyspepsia, allergic reactions. Proxibarbal enhances the effects of other depriving agents, including alcohol.

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:16:05 GMT 2023
Edited
by admin
on Sat Dec 16 10:16:05 GMT 2023
Record UNII
RE966VDY2Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PROXIBARBAL, (+)-
Common Name English
2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-(2-HYDROXYPROPYL)-5-(2-PROPENYL)-, (+)-
Systematic Name English
2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-(2-HYDROXYPROPYL)-5-(2-PROPEN-1-YL)-, (+)-
Systematic Name English
D-5-ALLYL-5-(.BETA.-HYDROXYPROPYL)BARBITURIC ACID
Common Name English
Code System Code Type Description
PUBCHEM
17336
Created by admin on Sat Dec 16 10:16:05 GMT 2023 , Edited by admin on Sat Dec 16 10:16:05 GMT 2023
PRIMARY
FDA UNII
RE966VDY2Y
Created by admin on Sat Dec 16 10:16:05 GMT 2023 , Edited by admin on Sat Dec 16 10:16:05 GMT 2023
PRIMARY
CAS
42013-23-0
Created by admin on Sat Dec 16 10:16:05 GMT 2023 , Edited by admin on Sat Dec 16 10:16:05 GMT 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> ENANTIOMER